Forsythoside B
(Synonyms: 连翘酯苷 B) 目录号 : GN10727Forsythoside B是从传统中药植物连翘的叶子中分离的一种苯乙醇苷,具有多种生物活性,能够用于治疗炎症性疾病和促进血液循环。
Cas No.:81525-13-5
Sample solution is provided at 25 µL, 10mM.
Forsythoside B is a phenylethanol glycoside isolated from the leaves of the traditional Chinese medicinal plant Forsythia suspensa. It has multiple biological activities and can be used to treat inflammatory diseases and promote blood circulation[1]. Forsythoside B can target pneumolysin to reduce the virulence of Streptococcus pneumoniae[2]. Forsythoside B exhibits effective antibacterial activity against Pseudomonas aeruginosa and Acinetobacter baumannii[3].
In vitro, pretreatment of BV-2 cells with Forsythoside B (1, 2.5µM) for 3h significantly inhibited the LPS-induced increase in intracellular IL-6, TNF-α, iNOs, NO and IL-1β[4]. Pretreatment of RAW 264.7 macrophages with Forsythoside B (40, 80, 160μg/mL) for 1h significantly inhibited the LPS-induced increase in intracellular PGE2, COX-2, nitrite and iNOS[5].
In vivo, Forsythoside B (40mg/kg) was intravenously injected into rats with cecal ligation and puncture (CLP)-induced sepsis, which reduced serum TNF-α, IL-6, HMGB1, triggering receptor expressed on myeloid cells (TREM-1), and endotoxin levels, upregulated IL-10 levels, and reduced myeloperoxidase (MPO) activity in the lungs, liver, and small intestine[6]. Forsythoside B (10, 40mg/kg) was intraperitoneally injected into mice with spinal cord injury (SCI), which significantly reduced the levels of inflammatory factors, inhibited glial scar formation, reduced neuronal death and tissue defects, and promoted motor recovery[7].
References:
[1] Bailly C. Forsythosides as essential components of Forsythia-based traditional Chinese medicines used to treat inflammatory diseases and COVID-19[J]. World Journal of Traditional Chinese Medicine, 2022, 8(1): 1-20.
[2] Wang Z, Sun Y, Gu K, et al. Forsythoside B, the active component of Frosythiae fructuse water extract, alleviates Streptococcus pneumoniae virulence by targeting pneumolysin[J]. Journal of Applied Microbiology, 2024, 135(10): lxae251.
[3] Shi Z, Zhang J, Wang Y, et al. Antibacterial effect and mechanisms of action of forsythoside B, alone and in combination with antibiotics, against Acinetobacter baumannii and Pseudomonas aeruginosa[J]. Phytomedicine, 2024, 135: 156038.
[4] Kong F, Jiang X, Wang R, et al. Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer’s disease[J]. Journal of Neuroinflammation, 2020, 17: 1-15.
[5] Liu J, Li X, Yan F, et al. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway[J]. International Immunopharmacology, 2019, 66: 336-346.
[6] Jiang W L, Zhang S P, Zhu H B. Forsythoside B protects against experimental sepsis by modulating inflammatory factors[J]. Phytotherapy Research, 2012, 26(7): 981-987.
[7] Xia M, Zhang Y, Wu H, et al. Forsythoside B attenuates neuro-inflammation and neuronal apoptosis by inhibition of NF-κB and p38-MAPK signaling pathways through activating Nrf2 post spinal cord injury[J]. International Immunopharmacology, 2022, 111: 109120.
Forsythoside B是从传统中药植物连翘的叶子中分离的一种苯乙醇苷,具有多种生物活性,能够用于治疗炎症性疾病和促进血液循环[1]。Forsythoside B能够靶向肺溶血素来减轻肺炎链球菌的毒力[2]。Forsythoside B对铜绿假单胞菌和鲍曼不动杆菌表现出有效的抗菌活性[3]。
在体外,Forsythoside B(1,2.5µM)预处理BV-2细胞3h,显著抑制了LPS诱导的细胞内IL-6、TNF-α、iNOs、NO和IL-1β升高[4]。Forsythoside B(40、80、160μg/mL)预处理RAW 264.7巨噬细胞1h,显著抑制了LPS诱导的细胞内PGE2、COX-2、亚硝酸盐、iNOS的升高[5]。
在体内,Forsythoside B(40mg/kg)通过静脉注射治疗盲肠结扎穿刺(CLP)诱导的脓毒症大鼠,降低了血清TNF-α、IL-6、HMGB1、髓系细胞上表达的触发受体(TREM-1)和内毒素水平,上调了IL-10水平,降低了肺、肝和小肠髓过氧化物酶(MPO)活性[6]。Forsythoside B(10、40mg/kg)通过腹腔注射治疗脊髓损伤(SCI)小鼠,显著降低了炎症因子的水平,抑制了神经胶质瘢痕形成,减少了神经元死亡、组织缺陷,促进了运动恢复[7]。
Cell experiment [1]: | |
Cell lines | BV-2 cells |
Preparation Method | BV-2 cells seeded into 96-well plates were pretreated with 1μM and 2.5μM Forsythoside B or PBS for 3h. Then co-incubated with 1μg/mL LPS dissolved in DMEM for 24h. |
Reaction Conditions | 1, 2.5µM; 3h |
Applications | The LPS-induced enhancements of IL-6, TNF-α, iNOs, NO, and IL-1β in BV-2 cells were strongly suppressed by Forsythoside B pre-incubation. |
Animal experiment [2]: | |
Animal models | Sprague-Dawley rats |
Preparation Method | Forty caecal ligation and puncture (CLP) rats were divided into four subgroups, with 10 rats in each group: (i) CLP (model group); (ii) Forsythoside B 40mg/kg group; (iii) Imipenem 20mg/kg group; (iv) Imipenem 20mg/kg+Forsythoside B 40mg/kg group. All rats received only two doses of Forsythiaside B, which were intravenously injected (i.v.) at 1h and 13h after CLP, and the small intestine, liver, and lung were collected for biochemical analysis at 20h after CLP. |
Dosage form | 40mg/kg; i.v. |
Forsythoside B can reduce serum TNF-α, IL-6, HMGB1, triggering receptor expressed on myeloid cells (TREM-1) and endotoxin levels, while serum IL-10 levels are upregulated and lung, liver and small intestine myeloperoxidase (MPO) levels are decreased. | |
References: |
Cas No. | 81525-13-5 | SDF | |
别名 | 连翘酯苷 B | ||
化学名 | [(2R,3R,4R,5R,6R)-2-[[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate | ||
Canonical SMILES | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)COC4C(C(CO4)(CO)O)O)OCCC5=CC(=C(C=C5)O)O)O)O)O)O | ||
分子式 | C34H44O19 | 分子量 | 756.7 |
溶解度 | ≥ 35.6mg/mL in EtOH with ultrasonic; 100 mg/mL in DMSO; 100 mg/mL in Water | 储存条件 | Store at -20°C,protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.3215 mL | 6.6076 mL | 13.2153 mL |
5 mM | 0.2643 mL | 1.3215 mL | 2.6431 mL |
10 mM | 0.1322 mL | 0.6608 mL | 1.3215 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet